ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ÑÕ¹âÃÀÍŶÓÅжϳöM1²¡¶¾µÄÌØÒìÐÔÊÜÌ壬µÓÚ¨OVM¾«×¼ÁÆ·¨µÄ¿ÆÑ§»ù´¡

¸å¼þȪԴ£º£º£ºÖÐɽҽѧԺ ±à¼­£º£º£ºÖ£Áú·É ¡¢¡¢¡¢Íõ¶¬Ã· ÔĶÁÁ¿£º£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±²Ì¾²£©ÈÜÁö²¡¶¾ÁÆ·¨ÊÇÒ»ÖÖÐÂÐ͵ĶñÐÔÖ×ÁöÃâÒßÖÎÁÆÕ½ÂÔ£¬¾ßÓи߰ÐÏòÐÔ ¡¢¡¢¡¢¶à»úÖÆÈÜÁöºÍ¿É±à¼­Ë¢ÐµÈÓÅÊÆ£¬ÕýÔÚÖð½¥³ÉΪÖ×ÁöÃâÒßÖÎÁƵÄÈÈÃÅÁìÓò¡£Ö»¹ÜÈÜÁö²¡¶¾ÔÚ²¿·ÖÄÑÖÎÐÔ¶ñÐÔÖ×Áö²¡ÈËÉÏÈ¡µÃÁ˾ªÈ˵ÄÁÆÐ§£¬ÈÔÓкܴó±ÈÀýµÄ²¡ÈËÎÞ·¨´ÓÖлñÒæ£¬Æä»ù´¡Ô­ÒòÔÚÓÚȱ·¦ÓÃÓÚÇø·ÖÏìÓ¦»¼ÕߺͷÇÏìÓ¦»¼Õߵľ«×¼Õï¶ÏÉúÎï±ê¼ÇÎï¡£

ƾ֤²¡¶¾µÄÉúÑÄÊ·ÌØµã£¬ÈÜÁö²¡¶¾¶ÔÖ×ÁöµÄɱÃðÈ¡¾öÓÚÁ½¸öÒªº¦·½·¨£º£º£ºÍ¨¹ý°ûĤÊÜÌå½øÈëÖ×Áöϸ°ûºÍÔÚ°ûÄÚÀÖ³ÉÍê³É»ùÒò×鏴֯£¬ÕâÌáÐÑÈÜÁö²¡¶¾±£´æ°ûĤÐͺͰûÄÚÐÍÁ½´óÀà±ê¼ÇÎï¡£ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÑÕ¹âÃÀ½ÌÊÚÍŶÓÓÚ2014Ä꽫M1²¡¶¾Ô­´´ÐÔµØÅжÏΪһÖÖÐÂÐÍÈÜÁö²¡¶¾£¨PNAS, 2014£©ºó£¬Â½Ðø·¢Ã÷ÁËËĸöÔ¤ÅÐM1²¡¶¾ÁÆÐ§µÄ°ûÄÚÐÍÉúÎï±ê¼ÇÎ»®·ÖÊÇпָ¿¹²¡¶¾ÂѰ×ZAP£¨Oncogene, 2020£© ¡¢¡¢¡¢µ¨¹Ì´¼Í¨Â·Ïà¹ØÂѰ×RHOQ£¨Nature Communications, 2018£© ¡¢¡¢¡¢ÄÚÖÊÍøÓ¦¼¤Í¨Â·ÂѰ×IRE1¦Á£¨Journal of Virology, 2018£©ºÍKRASÍ»±ä£¨Molecular Oncology, 2020£©¡£

2022Äê4ÔÂ8ÈÕ£¬ÑÕ¹âÃÀ½ÌÊÚÍŶÓÔÚÖ÷Òª×ÅÃû¿ÆÑ§ÆÚ¿¯Signal transduction and targeted therapy£¨STTT£©ÔÓÖ¾ÔÚÏß½ÒÏþÌâΪ¡°Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors¡±µÄArticleÑо¿ÂÛÎÄ¡£¸ÃÑо¿ÅжÏÁËMXRA8ΪÐÂÐÍÈÜÁö²¡¶¾M1£¨OVM£©µÄÊÜÌ壬ԭ´´ÐÔµØÈ·¶¨ÁËÔ¤²âM1²¡¶¾ÁÆÐ§µÄË«ÉúÎï±ê¼ÇÎdual-biomarker£©ÏµÍ³¡£

ÔÚ±¾ÏîÑо¿ÖУ¬Ñо¿ÍŶÓÊ×ÏÈʹÓöàϸ°ûת¼×éѧ¾ÙÐÐWeighted Gene Co-Expression Network Analysis£¨WGCNA£©ÆÊÎö£¬É¸Ñ¡³öĤÂѰ×MXRA8Êǽ鵼M1²¡ð²É±ÉËÖ×Áöϸ°ûµÄÒªº¦ËÞÖ÷Òò×Ó£»£»ËæºóµÄϸ°ûˮƽºÍ¶¯Îïˮƽ¹ý±í´ïºÍÇóýʵÑé֤ʵMXRA8ÕýÏòµ÷¿ØM1²¡¶¾µÄÈÜÁöЧӦ£»£»½øÒ»²½µØ£¬Ñо¿Ö°Ô±Ê¹ÓÃÀä¶³µç¾µÊÖÒÕ»ñµÃÁËMXRA8ÓëM1²¡¶¾ÏàÁ¬ÏµµÄµÍ·Ö±æÂʽṹ£¬Ö±¹ÛµØÖ¤ÊµMXRA8ÊÇM1²¡¶¾µÄÊÜÌ塣ͬʱ£¬Ñо¿Ö°Ô±·¢Ã÷MXRA8ÔÚʵÌåÁöÖÐÆÕ±é¸ß±í´ï£¬Æä±í´ïÁ¿ÏÔÖø¸ßÓÚ°©ÅÔÅä¶ÔÕý³£×éÖ¯¡£ÒÔÉÏЧ¹ûÌáÐÑÊÜÌåMXRA8¿É×÷ΪM1²¡¶¾µÄ°ûĤÐÍÉúÎï±ê¼ÇÎï¡£Ö÷ÒªµÄÊÇ£¬Ñо¿Ö°Ô±·¢Ã÷ÔÚÖ×Áöϸ°ûÖêºÍ²¡ÈËÖ×Áö×éÖ¯ÖУ¬ZAPµÄµÍ±í´ïºÍMXRA8µÄ¸ß±í´ïÄÜÅäºÏÔ¤²âM1²¡¶¾µÄ×éÖ¯»îÐÔÒÖÖÆÄÜÁ¦¡£×ÛÉÏËùÊö£¬¸ÃÑо¿ÅжÏÁËÐÂÐÍÈÜÁö²¡¶¾M1µÄÊÜÌ壬²¢Ìá³öʹÓðûĤÊÜÌåMXRA8ºÍËÞÖ÷Òò×ÓZAP×öΪԤ²âM1²¡¶¾ÁÆÐ§µÄË«ÉúÎï±ê¼ÇÎdual-biomarker£©ÏµÍ³¡£¸ÃÑо¿½«Íƶ¯M1²¡¶¾µÄ¾«×¼Õï¶ÏºÍÁÙ´²×ª»¯£¬²¢ÎªÈÜÁö²¡¶¾ÁÆ·¨µÄÉúÎï±ê¼ÇÎïÑо¿Ìṩ·¶Ê½¡£

Ê×Ò³|ngµç×ÓÓÎÏ·Öйú¼¯ÍŹٷ½ÍøÕ¾

ͼע£º£º£ºÐÂÐÍÈÜÁö²¡¶¾M1µÄÁÆÐ§Ô¤²âdual-biomarker×÷ÓûúÀí

ÖÐɽҽѧԺÑÕ¹âÃÀ½ÌÊÚÍŶӵIJ̾²¸±Ñо¿Ô±ºÍÁÖÔ°¸±½ÌÊÚΪ±¾ÎĵÄÅäºÏͨѶ×÷Õߣ¬²©Ê¿ÉúËεÂÁ¦ ¡¢¡¢¡¢¼ÖÐñ¶« ¡¢¡¢¡¢ÁøöγǺͺúÁÕñ´Îª±¾ÎĵÄÅäºÏµÚÒ»×÷Õß¡£ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§ÔºµÄÕÅÇÚÀ͸±½ÌÊÚΪ±¾ÎĵÄÀä¶³µç¾µÑо¿×ö³öÁËÖ÷ҪТ˳¡£ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĵÄÈü¿Ë¸±Ö÷ÈÎҽʦºÍngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºµÄºú³É¸±Ö÷ÈÎҽʦΪ±¾ÎÄÌṩÁË´ó×ÚÖ×Áö×éÖ¯±ê±¾¡£±¾ÎÄ»ñµÃÁ˹ú¼ÒÖØµãÑз¢ÍýÏë ¡¢¡¢¡¢¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÃæÉÏÏîÄ¿ ¡¢¡¢¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðºÍngµç×ÓÓÎÏ·ÖÐɽҽѧԺ-Á¥ÊôµÚÒ»Ò½ÔºÏȽøÒ½Ñ§¿ÆÑ§ÊÖÒÕÑо¿ÖÐÐĵÄÖ§³Ö¡£

ÂÛÎÄÁ´½Ó£º£º£ºhttps://www.nature.com/articles/s41392-022-00921-3

¡¾ÍøÕ¾µØÍ¼¡¿